Cardiac tissue engineering is a promising strategy to prevent heart failure. However, several
issues remain unsolved, including efficient electrical coupling and incorporating factors to …

The development of advanced biomaterials is a crucial step to enhance the efficacy of tissue
engineering strategies for treatment of myocardial infarction. Specific characteristics of …

Cardiac tissue engineering is a promising strategy to treat heart failure. Yet, several issues
remain to be resolved including the prevention of arrhythmia caused by inefficient electrical …

The field of cardiac tissue engineering has made significant strides in therapeutic and
pharmaceutical applications, highlighted by the development of smart biomaterials …

Cardiomyocytes differentiated from human induced pluripotent stem cells (hiPSCs) offer
tremendous potential when used to engineer human tissues for drug screening and disease …

Among non-communicable diseases, cardiovascular diseases are the most prevalent,
accounting for approximately 17 million deaths per year. Despite conventional treatment …

Cardiovascular diseases represent a major socio-economic burden. In recent years,
considerable effort has been invested in optimizing cell delivery strategies to advance cell …

Cell therapy offers a promising paradigm for heart tissue regeneration. Human induced
pluripotent stem cells (hiPS) and their cardiac derivatives are emerging as a novel treatment …

Injectable hydrogels which mimic the physicochemical and electromechanical properties of
cardiac tissue is advantageous for cardiac tissue engineering. Here, a newly-developed in …

Cardiovascular diseases are the leading cause of death today and a significant public
health problem. Currently, there is no proper treatment for major cardiovascular diseases …